Michael A. Kutcher , MD

About Me

Education: BS, St Francis College, 1970; MD, Jefferson Medical College, 1974
Internship: Medicine, St Vincent's Hospital - Medical Center - New York, 1975
Residency: Medicine, St Vincent's Hospital - Medical Center - New York, 1978
Fellowship: Emory University School of Medicine, 1981
Board Certifications: American Board of Internal Medicine, Cardiovascular Disease; American Board of Internal Medicine, Internal Medicine; American Board of Internal Medicine, Interventional Cardiology
Memberships: Forsyth-Davie-Stokes Medical Society; Health Sciences Communications Association; American College of Cardiology; American College of Physicians; American Federation of Clinical Research; American Heart Association
Positions: Professor, Cardiology
Departments and Affiliations: Cardiology

Biodegradable-Polymer Drug-Eluting Stent Platforms: The Importance of Long-Term Outcomes.. Kutcher MA. JACC Cardiovasc Interv. 2018 May; 11(10):1003-1005.
Bioresorbable Vascular Scaffold Thrombosis: Solutions to the Problem?. Kutcher MA. JACC Cardiovasc Interv. 2017 Sep; 10(18):1816-1818.
The Bioresorbable Drug-Eluting Coronary Stent: The Price Is Right?. Kutcher MA. JACC Cardiovasc Interv. 2017 Apr; 10(8):783-785.
The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.. Vora AN, Peterson ED, McCoy LA, Garratt KN, Kutcher MA, Marso SP, Roe MT, Messenger JC, Rao SV. JACC Cardiovasc Interv. 2016 Apr; 9(8):771-779.
Door-to-Balloon Time as a Process Metric for Treatment of ST-Segment Elevation Myocardial Infarction: Time to "Tap Out"?. Kutcher MA. JACC Cardiovasc Interv. 2015 Dec; 8(15):1975-1977.

View More Publications